Skip to main content
Top
Published in: American Journal of Clinical Dermatology 1/2003

01-01-2003 | Practical Dermatology

Drug-Induced Nail Abnormalities

Authors: Dr Bianca Maria Piraccini, Matilde Iorizzo, Antonella Tosti

Published in: American Journal of Clinical Dermatology | Issue 1/2003

Login to get access

Abstract

This article reviews the different nail symptoms produced by drugs. Drug-induced nail abnormalities may result from toxicity to the matrix, the nail bed or the periungual tissues. The most common symptoms include Beau’s lines/onychomadesis, melanonychia, onycholysis, and periungual pyogenic granulomas. Nail changes usually affect several nails and in most cases are asymptomatic. Drugs that most frequently produce nail abnormalities include retinoids, indinavir, and cancer chemotherapeutic agents. In this article, we also include nail adverse effects as a result of radiotherapy since they are commonly observed in clinical practice.
Literature
1.
go back to reference Tosti A., Baran R., Dawber R.P.R. The nail in systemic diseases and drug-induced changes. In: Baran R., Dawber R.P.R., de Berker D.A.R., et al., editors. Baran and Dawber’s diseases of the nails and their management. 2nd ed. Oxford: Blackwell Science, 2001: 223–329CrossRef Tosti A., Baran R., Dawber R.P.R. The nail in systemic diseases and drug-induced changes. In: Baran R., Dawber R.P.R., de Berker D.A.R., et al., editors. Baran and Dawber’s diseases of the nails and their management. 2nd ed. Oxford: Blackwell Science, 2001: 223–329CrossRef
2.
go back to reference Piraccini B.M., Tosti A. Drug-induced nail disorders: incidence, management and prognosis. Drug Saf 1999 Sep; 21 (3): 187–201PubMedCrossRef Piraccini B.M., Tosti A. Drug-induced nail disorders: incidence, management and prognosis. Drug Saf 1999 Sep; 21 (3): 187–201PubMedCrossRef
3.
go back to reference Daniel III C.R., Scher R.K. Nail changes secondary to systemic drugs or ingestans. J Am Acad Dermatol 1984 Feb; 10 (2): 250–258PubMedCrossRef Daniel III C.R., Scher R.K. Nail changes secondary to systemic drugs or ingestans. J Am Acad Dermatol 1984 Feb; 10 (2): 250–258PubMedCrossRef
4.
go back to reference Daniel III C.R., Scher R.K. Nail changes secondary to systemic drugs and ingestans. In: Sher R.K., Daniel III C.R. Nails: therapy, diagnosis, surgery. Philadelphia (PA): WB Saunders Company, 1997: 251–275 Daniel III C.R., Scher R.K. Nail changes secondary to systemic drugs and ingestans. In: Sher R.K., Daniel III C.R. Nails: therapy, diagnosis, surgery. Philadelphia (PA): WB Saunders Company, 1997: 251–275
5.
6.
go back to reference Baran R., Kechijian P. Longitudinal melanonychia: diagnosis and management. J Am Acad Dermatol 1989 Dec; 21 (6): 1165–1175PubMedCrossRef Baran R., Kechijian P. Longitudinal melanonychia: diagnosis and management. J Am Acad Dermatol 1989 Dec; 21 (6): 1165–1175PubMedCrossRef
7.
go back to reference Vanhooteghem O., Richert B., Vindevoghel A., et al. Subungual abscess: an ungual side-effect related to docetaxel therapy. Br J Dermatol 2000 Aug; 43 (2): 445–473 Vanhooteghem O., Richert B., Vindevoghel A., et al. Subungual abscess: an ungual side-effect related to docetaxel therapy. Br J Dermatol 2000 Aug; 43 (2): 445–473
8.
go back to reference Hussain S., Anderson D.N., Salvatti M.E., et al. Onycholysis as a complication of systemic chemotherapy: report of five cases associated with prolonged weekly paclitaxel therapy and review of the literature. Cancer 2000 May; 88 (10): 2367–2371PubMedCrossRef Hussain S., Anderson D.N., Salvatti M.E., et al. Onycholysis as a complication of systemic chemotherapy: report of five cases associated with prolonged weekly paclitaxel therapy and review of the literature. Cancer 2000 May; 88 (10): 2367–2371PubMedCrossRef
9.
go back to reference Varotti C., Ghetti E., Piraccini B.M., et al. Subungual hematoma in a patient treated with an oral anticoagulant (warfarin sodium). Eur J Dermatol 1997; 7 (5): 395–396 Varotti C., Ghetti E., Piraccini B.M., et al. Subungual hematoma in a patient treated with an oral anticoagulant (warfarin sodium). Eur J Dermatol 1997; 7 (5): 395–396
10.
go back to reference Baran R. Etretinate and the nails (study of 130 cases): possible mechanisms of some side effects. Clin Exp Dermatol 1986; 11: 148–152PubMedCrossRef Baran R. Etretinate and the nails (study of 130 cases): possible mechanisms of some side effects. Clin Exp Dermatol 1986; 11: 148–152PubMedCrossRef
ai]11.
go back to reference Bouscarat F., Bouchard C., Bouhour D. Paronychia and pyogenic granuloma of the great toes in patients with indinavir. N Engl J Med 1998 Jun; 338 (24): 1776–1777PubMedCrossRef Bouscarat F., Bouchard C., Bouhour D. Paronychia and pyogenic granuloma of the great toes in patients with indinavir. N Engl J Med 1998 Jun; 338 (24): 1776–1777PubMedCrossRef
12.
go back to reference Calista D., Boschini A. Cutaneous side effects induced by indinavir. Eur J Dermatol 2000 Jun; 10 (4): 292–296PubMed Calista D., Boschini A. Cutaneous side effects induced by indinavir. Eur J Dermatol 2000 Jun; 10 (4): 292–296PubMed
13.
go back to reference Tosti A., Piraccini B.M., D’Antuono A., et al. Paronychia associated with antiretroviral therapy. Br J Dermatol 1999 May; 140 (5): 1165–1168PubMedCrossRef Tosti A., Piraccini B.M., D’Antuono A., et al. Paronychia associated with antiretroviral therapy. Br J Dermatol 1999 May; 140 (5): 1165–1168PubMedCrossRef
14.
go back to reference Stringer M.D., Bentley P.G. Peripheral gangrene associated with ß-blockade. Br J Surg 1986; 73: 1008–1011PubMedCrossRef Stringer M.D., Bentley P.G. Peripheral gangrene associated with ß-blockade. Br J Surg 1986; 73: 1008–1011PubMedCrossRef
15.
go back to reference Behrens S., Reuther T., Von Kobyletzki G., et al. Bleomycin induzierte PSS-artige pseudokeerodermie. Hautarzt 1998; 49: 725–729PubMedCrossRef Behrens S., Reuther T., Von Kobyletzki G., et al. Bleomycin induzierte PSS-artige pseudokeerodermie. Hautarzt 1998; 49: 725–729PubMedCrossRef
16.
go back to reference Wolf R., Tur E., Brenner S. Corticosteroid-induced “disappearing digit”. J Am Acad Dermatol 1990 Oct; 23 (4 Pt 1): 755–756PubMedCrossRef Wolf R., Tur E., Brenner S. Corticosteroid-induced “disappearing digit”. J Am Acad Dermatol 1990 Oct; 23 (4 Pt 1): 755–756PubMedCrossRef
17.
go back to reference Holmes L.B., Harvey E.A., Brown K.S., et al. Anti-convulsant teratogenesis I: a study design for newborn infants. Teratology 1994; 49: 202–207PubMedCrossRef Holmes L.B., Harvey E.A., Brown K.S., et al. Anti-convulsant teratogenesis I: a study design for newborn infants. Teratology 1994; 49: 202–207PubMedCrossRef
18.
go back to reference Pichini S., Altieri I., Zuccaro P., et al. Drug monitoring in non conventional biological fluids and matrices. Clin Pharmacokinet 1996 May–Jun; 30 (3): 221–228CrossRef Pichini S., Altieri I., Zuccaro P., et al. Drug monitoring in non conventional biological fluids and matrices. Clin Pharmacokinet 1996 May–Jun; 30 (3): 221–228CrossRef
19.
go back to reference Lemos N.P., Anderson R.A., Robertson J.R. Nail analysis for drugs of abuse: extraction and determination of cannabis in fingernails by RIA and GC-MS. J Anal Toxicol 1999 Mar; 23 (3): 147–152PubMed Lemos N.P., Anderson R.A., Robertson J.R. Nail analysis for drugs of abuse: extraction and determination of cannabis in fingernails by RIA and GC-MS. J Anal Toxicol 1999 Mar; 23 (3): 147–152PubMed
Metadata
Title
Drug-Induced Nail Abnormalities
Authors
Dr Bianca Maria Piraccini
Matilde Iorizzo
Antonella Tosti
Publication date
01-01-2003
Publisher
Springer International Publishing
Published in
American Journal of Clinical Dermatology / Issue 1/2003
Print ISSN: 1175-0561
Electronic ISSN: 1179-1888
DOI
https://doi.org/10.2165/00128071-200304010-00004

Other articles of this Issue 1/2003

American Journal of Clinical Dermatology 1/2003 Go to the issue

Adis Drug Evaluation

Terbinafine